FYFE; Matthew Colin Thor
Patent Applications and Registrations
Patent applications and USPTO patent grants for FYFE; Matthew Colin Thor.The latest application filed is for "itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune response".
Company Profile
10.61.94
- FYFE; Matthew Colin Thor - Oxfordshire GB
- Fyfe; Matthew Colin Thor - London GB
- Fyfe; Matthew Colin Thor - Chipping Norton GB
- Fyfe; Matthew Colin Thor - Barcelona ES
- Fyfe; Matthew Colin Thor - Oxford GB
- Fyfe; Matthew Colin Thor - Witney GB
Patent Activity
| Patent | Date |
|---|---|
| Itaconic Acid Derivatives And Uses Thereof Intreating An Inflammatory Disease Or A Disease Associated With An Undesirable Immune Response App 20220265595 - COOKE; Michael Liam ; et al. | 2022-08-25 |
| Kinase inhibitors Grant 10,941,115 - Baker , et al. March 9, 2 | 2021-03-09 |
| Kinase inhibitors Grant 10,882,859 - Fyfe January 5, 2 | 2021-01-05 |
| 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as janus kinase inhibitors Grant 10,851,097 - Fyfe December 1, 2 | 2020-12-01 |
| Kinase Inhibitors App 20200223843 - Fyfe; Matthew Colin Thor | 2020-07-16 |
| 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as Janus kinase inhibitors Grant 10,556,901 - Fyfe Feb | 2020-02-11 |
| Kinase Inhibitors App 20190330155 - BAKER; Thomas Matthew ; et al. | 2019-10-31 |
| Kinase inhibitors Grant 10,442,828 - Fyfe , et al. Oc | 2019-10-15 |
| Kinase inhibitors Grant 10,435,361 - Baker , et al. O | 2019-10-08 |
| Kinase inhibitors Grant 10,392,346 - Baker , et al. A | 2019-08-27 |
| (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 10,329,256 - Ortega Munoz , et al. | 2019-06-25 |
| Kinase inhibitors Grant 10,301,288 - Fyfe | 2019-05-28 |
| Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use Grant 10,233,178 - Ortega Munoz , et al. | 2019-03-19 |
| (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 10,214,477 - Ortega Munoz , et al. Feb | 2019-02-26 |
| Lysine specific demethylase-1 inhibitors and their use Grant 10,202,330 - Munoz , et al. Feb | 2019-02-12 |
| 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine And 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine Derivatives As Janus Kinase Inhibitors App 20180370963 - Fyfe; Matthew Colin Thor | 2018-12-27 |
| (hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20180354902 - Ortega Munoz; Alberto ; et al. | 2018-12-13 |
| Kinase inhibitors Grant 10,125,100 - Baker , et al. November 13, 2 | 2018-11-13 |
| Kinase Inhibitors App 20180319748 - BAKER; Thomas Matthew ; et al. | 2018-11-08 |
| 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine And 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine Derivatives As Janus Kinase Inhibitors App 20180319791 - Fyfe; Matthew Colin Thor | 2018-11-08 |
| Kinase Inhibitors App 20180305383 - FYFE; Matthew Colin Thor ; et al. | 2018-10-25 |
| Kinase inhibitors Grant 10,072,034 - Fyfe , et al. September 11, 2 | 2018-09-11 |
| (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,944,601 - Ortega Munoz , et al. April 17, 2 | 2018-04-17 |
| Kinase Inhibitors App 20180086741 - Fyfe; Matthew Colin Thor | 2018-03-29 |
| (hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20180079709 - ORTEGA MUNOZ; Alberto ; et al. | 2018-03-22 |
| Lysine demethylase inhibitors for myeloproliferative disorders Grant 9,908,859 - Baker , et al. March 6, 2 | 2018-03-06 |
| Kinase Inhibitors App 20180044288 - BAKER; Thomas Matthew ; et al. | 2018-02-15 |
| Urea derivatives useful as kinase inhibitors Grant 9,890,185 - Fyfe , et al. February 13, 2 | 2018-02-13 |
| Kinase inhibitors Grant 9,850,233 - Fyfe December 26, 2 | 2017-12-26 |
| Kinase inhibitor Grant 9,822,076 - Fyfe November 21, 2 | 2017-11-21 |
| Kinase inhibitors Grant 9,796,742 - Fyfe , et al. October 24, 2 | 2017-10-24 |
| Kinase inhibitors Grant 9,790,209 - Fyfe , et al. October 17, 2 | 2017-10-17 |
| Kinase Inhibitors App 20170291917 - FYFE; Matthew Colin Thor ; et al. | 2017-10-12 |
| Kinase inhibitors Grant 9,783,556 - Fyfe , et al. October 10, 2 | 2017-10-10 |
| Kinase inhibitors based upon N-alkyl pyrazoles Grant 9,771,353 - Fyfe September 26, 2 | 2017-09-26 |
| Kinase Inhibitors App 20170253563 - BAKER; Thomas Matthew ; et al. | 2017-09-07 |
| Kinase inhibitors Grant 9,751,837 - Baker , et al. September 5, 2 | 2017-09-05 |
| Kinase inhibitors Grant 9,732,063 - Frickel , et al. August 15, 2 | 2017-08-15 |
| Lysine Demethylase Inhibitors For Myeloproliferative Or Lymphoproliferative Diseases Or Disorders App 20170209432 - FYFE; Matthew Colin Thor ; et al. | 2017-07-27 |
| Kinase Inhibitors App 20170209445 - Fyfe; Matthew Colin Thor | 2017-07-27 |
| Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use Grant 9,708,309 - Ortega Munoz , et al. July 18, 2 | 2017-07-18 |
| Pyrazolyl-ureas as kinase inhibitors Grant 9,701,670 - Cariou , et al. July 11, 2 | 2017-07-11 |
| Cyclopropylamine derivatives useful as LSD1 inhibitors Grant 9,676,701 - Fyfe , et al. June 13, 2 | 2017-06-13 |
| (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,670,136 - Ortega Munoz , et al. June 6, 2 | 2017-06-06 |
| Kinase Inhibitor App 20170029378 - FYFE; Matthew Colin Thor | 2017-02-02 |
| (hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20170008844 - ORTEGA MUNOZ; Alberto ; et al. | 2017-01-12 |
| (hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20160368857 - ORTEGA MUNOZ; Alberto ; et al. | 2016-12-22 |
| Kinase Inhibitors App 20160340375 - FYFE; Matthew Colin Thor ; et al. | 2016-11-24 |
| Kinase Inhibitors App 20160340343 - FYFE; Matthew Colin Thor ; et al. | 2016-11-24 |
| Kinase inhibitor Grant 9,499,486 - Fyfe November 22, 2 | 2016-11-22 |
| (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,487,512 - Ortega Munoz , et al. November 8, 2 | 2016-11-08 |
| Kinase Inhibitors App 20160318909 - Fyfe; Matthew Colin Thor | 2016-11-03 |
| Urea Derivatives Useful As Kinase Inhibitors App 20160318958 - Fyfe; Matthew Colin Thor ; et al. | 2016-11-03 |
| Kinase inhibitors Grant 9,481,648 - Baker , et al. November 1, 2 | 2016-11-01 |
| (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,469,597 - Ortega Munoz , et al. October 18, 2 | 2016-10-18 |
| Kinase Inhibitors App 20160102059 - BAKER; Thomas Matthew ; et al. | 2016-04-14 |
| Kinase Inhibitor App 20160096805 - FYFE; Matthew Colin Thor | 2016-04-07 |
| Cyclopropylamine Derivatives Useful As Lsd1 Inhibitors App 20160052865 - FYFE; Matthew Colin Thor ; et al. | 2016-02-25 |
| Kinase Inhibitors Based Upon N-alkyl Pyrazoles App 20160039797 - FYFE; Matthew Colin Thor | 2016-02-11 |
| Kinase Inhibitors App 20160016934 - FYFE; Matthew Colin Thor | 2016-01-21 |
| Cyclopropylamine Inhibitors Of Oxidases App 20160000768 - Castro-Palomino Laria; Julio ; et al. | 2016-01-07 |
| Arylcyclopropylamine Based Demethylase Inhibitors Of Lsd1 And Their Medical Use App 20150376177 - ORTEGA MUNOZ; Alberto ; et al. | 2015-12-31 |
| Lysine Specific Demethylase-1 Inhibitors And Their Use App 20150368186 - MUNOZ; Alberto Ortega ; et al. | 2015-12-24 |
| Kinase Inhibitors App 20150329523 - FRICKEL; Fritz-Frieder ; et al. | 2015-11-19 |
| Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae Grant 9,186,337 - Baker , et al. November 17, 2 | 2015-11-17 |
| Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use Grant 9,181,198 - Ortega Munoz , et al. November 10, 2 | 2015-11-10 |
| Lysine specific demethylase-1 inhibitors and their use Grant 9,149,447 - Munoz , et al. October 6, 2 | 2015-10-06 |
| Lysine Demethylase Inhibitors For Myeloproliferative Disorders App 20150232436 - Baker; Jonathan Alleman ; et al. | 2015-08-20 |
| Kinase Inhibitors App 20150225373 - Fyfe; Matthew Colin Thor ; et al. | 2015-08-13 |
| Kinase Inhibitors App 20150225427 - Fyfe; Matthew Colin Thor ; et al. | 2015-08-13 |
| Pyrazolyl-ureas As Kinase Inhibitors App 20150218137 - Cariou; Claire Anne Marie ; et al. | 2015-08-06 |
| Kinase Inhibitors App 20150210722 - Fyfe; Matthew Colin Thor ; et al. | 2015-07-30 |
| Cyclopropylamine inhibitors of oxidases Grant 9,061,966 - Laria , et al. June 23, 2 | 2015-06-23 |
| Kinase Inhibitors App 20150166483 - FYFE; Matthew Colin Thor | 2015-06-18 |
| (hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20150119396 - Ortega Munoz; Alberto ; et al. | 2015-04-30 |
| Cyclopropylamine derivatives useful as LSD1 inhibitors Grant 9,006,449 - Fyfe , et al. April 14, 2 | 2015-04-14 |
| Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use Grant 8,946,296 - Ortega Munoz , et al. February 3, 2 | 2015-02-03 |
| (hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20150025054 - Ortega Munoz; Alberto ; et al. | 2015-01-22 |
| Kinase inhibitor Grant 8,927,563 - Fyfe January 6, 2 | 2015-01-06 |
| Lysine Specific Demethylase-1 inhibitors and their use Grant 8,859,555 - Ortega Munoz , et al. October 14, 2 | 2014-10-14 |
| Kinase Inhibitors App 20140296208 - BAKER; Thomas Matthew ; et al. | 2014-10-02 |
| Kinase Inhibitor App 20140296271 - FYFE; Matthew Colin Thor | 2014-10-02 |
| (hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20140256729 - Ortega Munoz; Alberto ; et al. | 2014-09-11 |
| Lysine Specific Demethylase-1 Inhibitors And Their Use App 20140213657 - MUNOZ; Alberto Ortega ; et al. | 2014-07-31 |
| Lysine Demethylase Inhibitors For Myeloproliferative Or Lymphoproliferative Diseases Or Disorders App 20140163041 - Fyfe; Matthew Colin Thor ; et al. | 2014-06-12 |
| Lysine specific demethylase-1 inhibitors and their use Grant 8,722,743 - Ortega Munoz , et al. May 13, 2 | 2014-05-13 |
| Kinase Inhibitors App 20140057915 - CARIOU; CLAIRE ANNE MARIE ; et al. | 2014-02-27 |
| Cyclopropylamine Inhibitors Of Oxidases App 20130289076 - Laria; Julio Castro-Palomino ; et al. | 2013-10-31 |
| Arylcyclopropylamine Based Demethylase Inhibitors Of Lsd1 And Their Medical Use App 20130231342 - Munoz; Alberto Ortega ; et al. | 2013-09-05 |
| Lysine Demethylase Inhibitors For Diseases And Disorders Associated With Hepadnaviridae App 20130095067 - Baker; Jonathan Alleman ; et al. | 2013-04-18 |
| Lysine Specific Demethylase-1 Inhibitors And Their Use App 20130090386 - Ortega Munoz; Alberto ; et al. | 2013-04-11 |
| Lysine Specific Demethylase-1 Inhibitors And Their Use App 20120283266 - Ortega Munoz; Alberto ; et al. | 2012-11-08 |
| Substituted Heteroaryl- And Aryl-cyclopropylamine Acetamides And Their Use App 20120264823 - Ortega Munoz; Alberto ; et al. | 2012-10-18 |
| Aryl Urea Derivatives for Treating Obesity App 20120214808 - Bloxham; Jason ; et al. | 2012-08-23 |
| GPCR Agonists App 20120172358 - Bradley; Stuart Edward ; et al. | 2012-07-05 |
| Heterocyclic derivatives as GPCR receptor agonists Grant 8,207,147 - Fyfe , et al. June 26, 2 | 2012-06-26 |
| G-protein coupled receptor agonists Grant 8,193,359 - Fyfe , et al. June 5, 2 | 2012-06-05 |
| Pyridine, pyrimidine and pyrazine derivatives as GPCR agonists Grant 8,173,807 - Bradley , et al. May 8, 2 | 2012-05-08 |
| Compounds for the Treatment of Metabolic Disorders App 20120077793 - Barba; Oscar ; et al. | 2012-03-29 |
| Compounds for the Treatment of Metabolic Disorders App 20120059014 - Barba; Oscar ; et al. | 2012-03-08 |
| Compounds for the Treatment of Metabolic Disorders App 20120040953 - Barba; Oscar ; et al. | 2012-02-16 |
| Piperidinyl Gpcr Agonists App 20110269734 - Bertram; Lisa Sarah ; et al. | 2011-11-03 |
| Piperidine GPCR Agonists App 20110230507 - Bertram; Lisa Sarah ; et al. | 2011-09-22 |
| Heterocyclic GPCR Agonists App 20110212939 - Bertram; Lisa Sarah ; et al. | 2011-09-01 |
| Piperidinyl GPCR Agonists App 20110195994 - Bertram; Lisa Sarah ; et al. | 2011-08-11 |
| Heterocyclic GPCR Agonists App 20110178054 - Bertram; Lisa Sarah ; et al. | 2011-07-21 |
| Azetidinyl G-protein Coupled Receptor Agonists App 20100286110 - Fyfe; Matthew Colin Thor ; et al. | 2010-11-11 |
| Compounds For The Treatment Of Metabolic Disorders App 20100286112 - Barba; Oscar ; et al. | 2010-11-11 |
| Substituted phenylacetamides and their use as glucokinase activators Grant 7,745,491 - Fyfe , et al. June 29, 2 | 2010-06-29 |
| Piperidine Gpcr Agonists App 20100105732 - Fyfe; Matthew Colin Thor ; et al. | 2010-04-29 |
| Piperidine GPCR Agonists App 20100048631 - Fyfe; Matthew Colin Thor ; et al. | 2010-02-25 |
| Piperidine GPCR Agonists App 20100048632 - Fyfe; Matthew Colin Thor ; et al. | 2010-02-25 |
| Piperidine Gpcr Agonists App 20100048625 - Fyfe; Matthew Colin Thor ; et al. | 2010-02-25 |
| Pyridine, pyrimidine and pyrazine derivatives as gpcr agonists App 20100035897 - Bradley; Stuart Edward ; et al. | 2010-02-11 |
| Piperidine Gpcr Agonists App 20100022591 - Bertram; Lisa Sarah ; et al. | 2010-01-28 |
| Azetidine Derivatives as G-Protein Coupled Receptor (GPR119) Agonists App 20090281076 - Fyfe; Matthew Colin, Thor ; et al. | 2009-11-12 |
| Gpcr Agonists App 20090221644 - Bradley; Stuart Edward ; et al. | 2009-09-03 |
| Heterocyclic GPCR Agonists App 20090221639 - Bertram; Lisa Sarah ; et al. | 2009-09-03 |
| Enantioselective Process App 20090221824 - Briner; Paul Howard ; et al. | 2009-09-03 |
| Tri(cyclo) substituted amide compounds Grant 7,582,632 - Fyfe , et al. September 1, 2 | 2009-09-01 |
| G-protein Coupled Receptor Agonists App 20090203676 - Barba; Oscar ; et al. | 2009-08-13 |
| G-Protein Coupled Receptor Agonists App 20090099227 - Fyfe; Matthew Colin Thor ; et al. | 2009-04-16 |
| Substituted Phenylacetamides And Their Use As Glucokinase Activators App 20090054444 - Fyfe; Matthew Colin Thor ; et al. | 2009-02-26 |
| Tricyclo Substituted Amides App 20090005391 - Fyfe; Matthew Colin Thor ; et al. | 2009-01-01 |
| G-Protein Coupled Receptor (Gpr116) Agonists and Use Thereof for Treating Obesity and Diabetes App 20080312281 - Fyfe; Matthew Colin Thor ; et al. | 2008-12-18 |
| Tricyclo Substituted Amides as Glucokinase Modulators App 20080293741 - Fyfe; Matthew Colin Thor ; et al. | 2008-11-27 |
| Tricyclo Substituted Amides App 20080293730 - Fyfe; Matthew Colin Thor ; et al. | 2008-11-27 |
| Aryl Urea Derivatives for Treating Obesity App 20080261952 - Bloxham; Jason ; et al. | 2008-10-23 |
| Fluorination Process of Protected Aminothiazole App 20080015358 - Fyfe; Matthew Colin Thor ; et al. | 2008-01-17 |
| Tri(cyclo) Substituted Amide Compounds App 20070281946 - Fyfe; Matthew Colin Thor ; et al. | 2007-12-06 |
| Tri(cyclo) substituted amide glucokinase activator compounds Grant 7,262,196 - Fyfe , et al. August 28, 2 | 2007-08-28 |
| Tri(cyclo) substituted amide compounds Grant 7,214,681 - Fyfe , et al. May 8, 2 | 2007-05-08 |
| Benzyl urea and thiourea derivatives Grant 7,115,745 - Du , et al. October 3, 2 | 2006-10-03 |
| Benzyl sulfonamide derivatives Grant 7,098,340 - Du , et al. August 29, 2 | 2006-08-29 |
| Urea and thiourea derivatives Grant 7,074,933 - Du , et al. July 11, 2 | 2006-07-11 |
| Androgen receptor antagonists Grant 7,064,207 - Du , et al. June 20, 2 | 2006-06-20 |
| Androgen receptor antagonists Grant 7,057,048 - Du , et al. June 6, 2 | 2006-06-06 |
| Benzyl urea and thiourea derivatives App 20050107427 - Du, Daniel Y. ; et al. | 2005-05-19 |
| Androgen receptor antagonists App 20050085466 - Du, Daniel Y. ; et al. | 2005-04-21 |
| Sulfonamide derivatives App 20050004367 - Du, Daniel Y. ; et al. | 2005-01-06 |
| Urea and thiourea derivatives App 20040266820 - Du, Daniel Y. ; et al. | 2004-12-30 |
| Tri(cyclo) substituted amide glucokinase activator compounds App 20040186290 - Fyfe, Matthew Colin Thor ; et al. | 2004-09-23 |
| Tri(cyclo) substituted amide compounds App 20040181067 - Fyfe, Matthew Colin Thor ; et al. | 2004-09-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 